ATE411803T1 - Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür - Google Patents

Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür

Info

Publication number
ATE411803T1
ATE411803T1 AT04713672T AT04713672T ATE411803T1 AT E411803 T1 ATE411803 T1 AT E411803T1 AT 04713672 T AT04713672 T AT 04713672T AT 04713672 T AT04713672 T AT 04713672T AT E411803 T1 ATE411803 T1 AT E411803T1
Authority
AT
Austria
Prior art keywords
medication
therefor
heart failure
severe heart
treating severe
Prior art date
Application number
AT04713672T
Other languages
German (de)
English (en)
Inventor
Atsushi Ozaki
Yosuke Maki
Osamu Sato
Yoshitaka Yamamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32908667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE411803(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE411803T1 publication Critical patent/ATE411803T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04713672T 2003-02-24 2004-02-23 Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür ATE411803T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44887803P 2003-02-24 2003-02-24

Publications (1)

Publication Number Publication Date
ATE411803T1 true ATE411803T1 (de) 2008-11-15

Family

ID=32908667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04713672T ATE411803T1 (de) 2003-02-24 2004-02-23 Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür

Country Status (23)

Country Link
US (2) US7423032B2 (enExample)
EP (2) EP2000142A1 (enExample)
JP (2) JP4771937B2 (enExample)
KR (1) KR100706727B1 (enExample)
CN (1) CN100577171C (enExample)
AR (1) AR043259A1 (enExample)
AT (1) ATE411803T1 (enExample)
AU (2) AU2004212842B9 (enExample)
BR (1) BRPI0405657A (enExample)
CA (1) CA2493475A1 (enExample)
CY (1) CY1108583T1 (enExample)
DE (1) DE602004017283D1 (enExample)
DK (1) DK1596868T3 (enExample)
ES (1) ES2315640T3 (enExample)
MX (1) MXPA05001623A (enExample)
MY (1) MY143740A (enExample)
NO (1) NO335369B1 (enExample)
PL (2) PL218069B1 (enExample)
PT (1) PT1596868E (enExample)
RU (2) RU2346689C2 (enExample)
SI (1) SI1596868T1 (enExample)
TW (1) TWI322689B (enExample)
WO (1) WO2004073716A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468390B2 (en) * 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
CA2633929A1 (en) 2005-12-27 2007-07-05 Otsuka Pharmaceutical Co., Ltd. Water-soluble benzoazepine compound and its pharmaceutical composition
JP5076327B2 (ja) * 2006-02-01 2012-11-21 味の素株式会社 分岐鎖アミノ酸の心不全適応
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
HRP20130920T1 (hr) * 2007-05-15 2013-11-08 Otsuka Pharmaceutical Co., Ltd. Postupak uporabe antagonista vazopresina s kemoterapijom antraciklina radi snižavanja kardiotoksiäśnosti i/ili poboljšanja stope preživljavanja
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
ES2903231T3 (es) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
WO2011147849A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
JP5477413B2 (ja) * 2012-04-24 2014-04-23 味の素株式会社 分岐鎖アミノ酸の心不全適応
JP6563394B2 (ja) 2013-08-30 2019-08-21 イェーナヴァルヴ テクノロジー インコーポレイテッド 人工弁のための径方向に折り畳み自在のフレーム及び当該フレームを製造するための方法
JP6829692B2 (ja) 2015-03-20 2021-02-10 イェーナヴァルヴ テクノロジー インコーポレイテッド 心臓弁プロテーゼ送出システム及び導入体シースにより心臓弁プロテーゼを送出するための方法
EP4403138A3 (en) 2015-05-01 2024-10-09 JenaValve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
CN109475419B (zh) 2016-05-13 2021-11-09 耶拿阀门科技股份有限公司 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
CN110174474B (zh) * 2019-05-24 2022-02-18 石家庄四药有限公司 复方电解质注射液(ⅱ)中l-苹果酸异构体的检测方法
CN112121051B (zh) * 2020-09-30 2021-06-18 郑州大学 莫扎伐坦在制备抗消化道肿瘤药物中的应用
JP2025538294A (ja) 2022-11-09 2025-11-27 イエナバルブ テクノロジー インク 拡張可能なインプラントの順次展開のためのカテーテルシステム

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102124A (ja) 1987-10-14 1989-04-19 Kubota Ltd コンクリート構造体支持構造
WO1991005549A1 (en) 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5753677A (en) * 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
EP0602209A1 (en) 1992-07-02 1994-06-22 Otsuka Pharmaceutical Co., Ltd. Oxytocin antagonist
JPH0680641A (ja) 1992-09-01 1994-03-22 Otsuka Pharmaceut Co Ltd 光学活性な５−ヒドロキシベンゾアゼピン誘導体の製造法
TW354762B (en) 1993-02-23 1999-03-21 Otsuka Pharma Co Ltd Agent for prophylaxis or treatment of cataract
JP2694319B2 (ja) 1993-12-24 1997-12-24 大塚製薬株式会社 抗潰瘍剤
JP3002766B2 (ja) 1994-12-09 2000-01-24 大塚製薬株式会社 脳浮腫治療剤
JPH10120592A (ja) 1996-10-22 1998-05-12 Otsuka Pharmaceut Co Ltd メニエール病乃至メニエール症候群治療剤
JP4210355B2 (ja) 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
BR0017074A (pt) 2000-01-26 2002-12-03 Warner Lambert Co Combinações de inibidor de ace-antagonista de vasopressina
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
US20030008860A1 (en) 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
CA2357833C (en) * 2000-10-04 2005-11-15 Warner-Lambert Company Treatment of pulmonary hypertension using vasopressin antagonist
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor

Also Published As

Publication number Publication date
AU2004212842A1 (en) 2004-09-02
PL373432A1 (en) 2005-08-22
NO20050569L (no) 2005-11-22
RU2346689C2 (ru) 2009-02-20
MY143740A (en) 2011-07-15
CA2493475A1 (en) 2004-09-02
PL218069B1 (pl) 2014-10-31
CN100577171C (zh) 2010-01-06
US20080214523A1 (en) 2008-09-04
DE602004017283D1 (de) 2008-12-04
HK1084037A1 (zh) 2006-07-21
TWI322689B (en) 2010-04-01
EP1596868A4 (en) 2006-03-29
MXPA05001623A (es) 2005-04-25
EP1596868A1 (en) 2005-11-23
AU2004212842B2 (en) 2009-01-08
PT1596868E (pt) 2009-01-14
JP2006518731A (ja) 2006-08-17
US7423032B2 (en) 2008-09-09
CN1700919A (zh) 2005-11-23
WO2004073716A1 (en) 2004-09-02
KR100706727B1 (ko) 2007-04-12
KR20050105972A (ko) 2005-11-08
RU2008133654A (ru) 2010-02-20
SI1596868T1 (sl) 2008-12-31
PL404315A1 (pl) 2013-08-05
ES2315640T3 (es) 2009-04-01
JP4771937B2 (ja) 2011-09-14
NO20050569D0 (no) 2005-02-02
CY1108583T1 (el) 2014-04-09
BRPI0405657A (pt) 2005-07-19
NO335369B1 (no) 2014-12-01
US20050187210A1 (en) 2005-08-25
EP1596868B1 (en) 2008-10-22
AU2009201109A1 (en) 2009-04-09
RU2005102110A (ru) 2005-09-20
TW200418489A (en) 2004-10-01
AU2004212842B9 (en) 2009-03-05
AR043259A1 (es) 2005-07-20
DK1596868T3 (da) 2008-12-08
EP2000142A1 (en) 2008-12-10
JP2011148806A (ja) 2011-08-04
US7749993B2 (en) 2010-07-06

Similar Documents

Publication Publication Date Title
ATE411803T1 (de) Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür
EP1701664A4 (en) SYSTEM AND METHOD FOR PROCESSING A FABRIC
EP1482962A4 (en) METHOD OF TREATING THIOREDOXIN-MEDIATED DISEASES (TRX)
EP1626730A4 (en) METHOD, DEVICE AND COMPOSITION FOR TREATING ACNE
EP1896083A4 (en) METHOD FOR TREATING PUMP DISEASE USING 1-DEOXYNOJIRIMYCIN AND ITS DERIVATIVES
ATE489955T1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
EP1651164A4 (en) COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISORDERS
EP1565230A4 (en) COMPOSITIONS OF MATERIALS AND ASSOCIATED SYSTEMS AND METHODS FOR THE TREATMENT OF CARDIAC CONDITIONS
DE602004021790D1 (de) Verfahren zur behandlung von parkinson-krankheit
EP1816990A4 (en) SYSTEMS, DEVICES AND METHODS FOR TREATING INTERVERTEBRAL DISORDERS
DE602006019753D1 (de) Verfahren und gerät zur behandlung von aneurysmen der a. thoracica
DE60334517D1 (de) System und Verfahren zur Durchführung von am-Chip Selbsttests
DE602004023829D1 (de) Verfahren zur behandlung von sinuskopfschmerzen
DE602005011656D1 (de) Verfahren zur behandlung von dickdarmkrebs mit botulinum neurotoxin
DE602005008970D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen mit retinyl-derivaten
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
EP1635801A4 (en) METHODS OF TREATMENT AND PREVENTION OF CARDIAC ARRHYTHMIA
ATE474602T1 (de) Verfahren zur behandlung von hiv-infektion
EP1550462A4 (en) REMEDY OR PREVENTIVE AGENT AGAINST KIDNEY DISEASE AND METHOD OF DIAGNOSING KIDNEY DISEASE
EP1487480A4 (en) HYBRID MOLECULES AND METHODS FOR TREATING IMMUNE DISEASES
DE602004001134D1 (de) Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit
EP1651237A4 (en) METHODS OF TREATING DERMATOLOGICAL DISORDERS
EP1684735A4 (en) COMPOUNDS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIAC ARRHYTHMIES INDUCED BY PHYSICAL EXERCISE
EP1592464A4 (en) METHOD OF TREATING COGNITIVE DECLINE FROM LACK OF SLEEP AND STRESS
DE602004010548D1 (de) Verfahren zur behandlung von tierhäuten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1596868

Country of ref document: EP